Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients

Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and payors

Lasix ONYU is the 17^th Captisol-enabled™ approved product

Read more at globenewswire.com